On July 20, East Buy (01797.HK) rose 5.74% in regular trading, reaching HK$23.86 per share with turnover of approximately HK$85.99 million.

On the news front, the company's private-label product sales demonstrated robust momentum, with cumulative Douyin store orders reaching 1.152 million units during July 13-19, averaging approximately 192,000 orders per day — achieving counter-seasonal growth during a traditionally weak period. Additionally, management previously confirmed plans to bind core anchor Dong Yuhui through equity participation rather than a traditional MCN commission model, aligning long-term interests. Market expectations around this structure continue to build.

Further supporting sentiment, the company launched a new low-GI grain dim sum series on July 17, expanding its proprietary health food matrix. The convergence of strong operational data, strategic talent retention mechanisms, and product pipeline expansion collectively drove positive market sentiment.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)